General Information
Drug ID
DR00627
Drug Name
Acebutolol
Synonyms
(+-)-3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; (+-)-Acebutolol; (+-)-N-(3-Acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)butanamide; 1-(2-Acetyl-4-n-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane; 3'-(Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; 3'-Acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide; 3'-Acetyl-4'-(2-hydroxy-3-isopropylaminopropoxy)butyranilid; 5'-Butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone; Acebrutololum; Acebrutololum [INN-Latin]; Acebutolol (USAN/INN); Acebutolol HCL; Acebutolol [USAN:INN:BAN]; Acebutololo; Acebutololum; Acebutololum [INN-Latin]; Acetobutolol; Acetobutolol [INN-Spanish]; Dl-Acebutolol; M & B 17803A; M&B-17803 A; N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide; N-[3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]butanamide; N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide; N-{3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}butanamide; Neptal; Prent; Prent (TN); RP 21823; Sectral; Sectral (TN)
Drug Type
Small molecular drug
Indication High blood pressure [ICD11: BA00] Approved [1]
Ventricular premature beats [ICD11: BC70] Approved [1]
Therapeutic Class
Antihypertensive Agents
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=1978"></iframe>
3D MOL 2D MOL
Formula
C18H28N2O4
Canonical SMILES
CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C
InChI
InChI=1S/C18H28N2O4/c1-5-6-18(23)20-14-7-8-17(16(9-14)13(4)21)24-11-15(22)10-19-12(2)3/h7-9,12,15,19,22H,5-6,10-11H2,1-4H3,(H,20,23)
InChIKey
GOEMGAFJFRBGGG-UHFFFAOYSA-N
CAS Number
CAS 37517-30-9
Pharmaceutical Properties Molecular Weight 336.432 Topological Polar Surface Area 87.7
Heavy Atom Count 24 Rotatable Bond Count 10
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 5
XLogP
1.7
PubChem CID
1978
PubChem SID
103189011 , 104299258 , 10520758 , 11335787 , 11361026 , 11363385 , 11365947 , 11368509 , 11371586 , 11374422 , 11376671 , 11461998 , 11466097 , 11467217 , 11485235 , 11485914 , 11489156 , 11490389 , 11492617 , 11494305 , 124883487 , 126443068 , 126679412 , 127982055 , 134337777 , 134999047 , 15075320 , 29221166 , 46509113 , 47216767 , 47216768 , 47291119 , 47365171 , 47365172 , 47440234 , 47810742 , 49698901 , 49895324 , 50427938 , 5199954 , 56413043 , 57321077 , 7849397 , 7978630 , 8148212 , 8151358 , 85209697 , 85787903 , 9022 , 99222788
ChEBI ID
ChEBI:2379
TTD Drug ID
D0HD9K
DT(s) Transporting This Drug OATP1A2 Transporter Info Organic anion transporting polypeptide 1A2 Substrate [2]
OCT1 Transporter Info Organic cation transporter 1 Substrate [3]
P-GP Transporter Info P-glycoprotein 1 Substrate [4]
References
1 Acebutolol was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Fruit juice inhibition of uptake transport: a new type of food-drug interaction. Br J Clin Pharmacol. 2010 Nov;70(5):645-55.
3 Implications of genetic polymorphisms in drug transporters for pharmacotherapy. Cancer Lett. 2006 Mar 8;234(1):4-33.
4 Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.